Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialDavies, Christina, Dr ; Pan, Hongchao, PhD ; Godwin, Jon, DPhil ; Gray, Richard, Prof ; Arriagada, Rodrigo, Prof ; Raina, Vinod, Prof ; Abraham, Mirta, MD ; Alencar, Victor Hugo Medeiros, MD ; Badran, Atef, PhD ; Bonfill, Xavier, MD ; Bradbury, Joan ; Clarke, Michael, Prof ; Collins, Rory, Prof ; Davis, Susan R, Prof ; Delmestri, Antonella, PhD ; Forbes, John F, Prof ; Haddad, Peiman, Prof ; Hou, Ming-Feng, Prof ; Inbar, Moshe, Prof ; Khaled, Hussein, Prof ; Kielanowska, Joanna, MD ; Kwan, Wing-Hong, MD ; Mathew, Beela S, MD ; Mittra, Indraneel, Prof ; Müller, Bettina, MD ; Nicolucci, Antonio, MD ; Peralta, Octavio, MD ; Pernas, Fany ; Petruzelka, Lubos, Prof ; Pienkowski, Tadeusz, Prof ; Radhika, Ramachandran, MD ; Rajan, Balakrishnan, MD ; Rubach, Maryna T, MD ; Tort, Sera, MD ; Urrútia, Gerard, MD ; Valentini, Miriam, MD ; Wang, Yaochen, MD ; Peto, Richard, ProfThe Lancet (British edition), 2013-03, Vol.381 (9869), p.805-816 [Peer Reviewed Journal]Kidlington: Elsevier LtdFull text available |